Sato S M, Hull E M
Department of Psychology, University at Buffalo, SUNY, Buffalo, NY 14260, USA.
Neuroscience. 2006 May 12;139(2):417-28. doi: 10.1016/j.neuroscience.2005.12.019. Epub 2006 Feb 17.
Dopamine in the medial preoptic area (MPOA) plays a significant role in regulation of male copulation. One mediator of the MPOA dopamine level is nitric oxide. In the current study, we investigated the role of the nitric oxide-guanosine 3',5'-cyclic monophosphate (cGMP) pathway in the regulation of MPOA dopamine and copulation in male rats. The reverse-dialysis of a membrane-permeable analog, 8-Br-cGMP, increased, while a soluble guanylyl cyclase inhibitor, 1H-[1,2,4]oxadiazole[4,3-a]quinoxalin-1-one (ODQ), significantly reduced basal dopamine and its metabolite levels. ODQ successfully blocked a nitric oxide donor-induced increase in dopamine levels, while a neuronal nitric oxide synthase (nNOS) inhibitor was ineffective in blocking an 8-Br-cGMP-induced increase in dopamine, indicating that cGMP is "downstream" of nitric oxide. Furthermore, 8-Br-cGMP facilitated, while ODQ inhibited copulation. Given the steroid-sensitive nature of nNOS functions and the multiple roles nitric oxide plays in the MPOA, we propose that nitric oxide provides important integration of various neurochemical and neuroendocrine signals. The involvement of the central nitric oxide-cGMP pathway in the regulation of copulation also raises an interesting therapeutic possibility, as the manipulation of the same pathway in peripheral tissue is already utilized in treatment of male sexual dysfunction.
内侧视前区(MPOA)中的多巴胺在雄性交配行为的调节中起着重要作用。一氧化氮是MPOA多巴胺水平的一种介质。在本研究中,我们调查了一氧化氮 - 鸟苷3',5'-环磷酸(cGMP)途径在雄性大鼠MPOA多巴胺调节和交配行为中的作用。膜通透性类似物8 - 溴 - cGMP的反向透析可提高多巴胺水平,而可溶性鸟苷酸环化酶抑制剂1H - [1,2,4]恶二唑[4,3 - a]喹喔啉 - 1 - 酮(ODQ)则显著降低基础多巴胺及其代谢物水平。ODQ成功阻断了一氧化氮供体诱导的多巴胺水平升高,而神经元型一氧化氮合酶(nNOS)抑制剂在阻断8 - 溴 - cGMP诱导的多巴胺升高方面无效,这表明cGMP位于一氧化氮的“下游”。此外,8 - 溴 - cGMP促进交配行为,而ODQ则抑制交配。鉴于nNOS功能对类固醇敏感的特性以及一氧化氮在MPOA中发挥的多种作用,我们提出一氧化氮为各种神经化学和神经内分泌信号提供了重要的整合作用。中枢一氧化氮 - cGMP途径参与交配行为的调节也提出了一种有趣的治疗可能性,因为外周组织中相同途径的调控已被用于治疗男性性功能障碍。